Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Publisher Correction: Adjuvant personalized multivalent neoantigen DNA vaccination for MGMT unmethylated glioblastoma: a phase 1 trial.
Journal: Nature cancer
Published: September 02, 2026
Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 07, 2026
Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 14, 2026
Tumor-mimicking primary CNS vasculitis: illustrative case.
Journal: Journal of neurosurgery. Case lessons
Published: February 26, 2026
A phase I window-of-opportunity study of neoadjuvant avelumab and hypofractionated radiation therapy in radiation-relapsed meningioma.
Journal: medRxiv : the preprint server for health sciences
Published: October 03, 2025
Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial.
Journal: Nature communications
Published: September 24, 2025
Eccrine carcinomas and homologous recombination repair cancer predisposition genes: A case series.
Journal: JAAD case reports
Published: September 15, 2025
NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 06, 2025
Circadian variation in MGMT promoter methylation and expression predicts sensitivity to temozolomide in glioblastoma.
Journal: Journal of neuro-oncology
Published: August 19, 2025
Diffusely metastatic glioblastoma with FGFR3::TACC3 fusion: cell-free DNA fragmentation analyses and molecular characterization of matched primary and metastatic tumor sites.
Journal: Acta neuropathologica communications
Published: July 30, 2025
Last Updated: 09/26/2026